JPM vs MSIF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
MSIF presents a classic 'value trap' profile, characterized by a critically weak Piotroski F-Score of 2/9 and a completely bearish technical trend (0/100). While the stock trades at a deep discount to its Graham Number ($26.1) and Intrinsic Value ($56.34), the deteriorating fundamental health and consistent earnings misses suggest significant underlying risk. The high dividend yield of 11.16% is attractive but may be unsustainable if the operational decline continues. Overall, the massive valuation gap is offset by poor financial health and negative price momentum.
Compare Another Pair
Related Comparisons
JPM vs MSIF: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and MSC Income Fund, Inc. (MSIF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.